JP2014534809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534809A5 JP2014534809A5 JP2014534027A JP2014534027A JP2014534809A5 JP 2014534809 A5 JP2014534809 A5 JP 2014534809A5 JP 2014534027 A JP2014534027 A JP 2014534027A JP 2014534027 A JP2014534027 A JP 2014534027A JP 2014534809 A5 JP2014534809 A5 JP 2014534809A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3310CH2011 | 2011-10-04 | ||
| IN3310/CHE/2011 | 2011-10-04 | ||
| PCT/IB2012/055334 WO2013050962A1 (en) | 2011-10-04 | 2012-10-04 | Ecm composition, tumor microenvironment platform and methods thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016177434A Division JP6378273B2 (ja) | 2011-10-04 | 2016-09-12 | Ｅｃｍ組成物、腫瘍微小環境プラットフォームおよびその方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534809A JP2014534809A (ja) | 2014-12-25 |
| JP2014534809A5 true JP2014534809A5 (enExample) | 2015-05-07 |
| JP6147259B2 JP6147259B2 (ja) | 2017-06-14 |
Family
ID=54261176
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014534027A Expired - Fee Related JP6147259B2 (ja) | 2011-10-04 | 2012-10-04 | Ｅｃｍ組成物、腫瘍微小環境プラットフォームおよびその方法 |
| JP2016177434A Expired - Fee Related JP6378273B2 (ja) | 2011-10-04 | 2016-09-12 | Ｅｃｍ組成物、腫瘍微小環境プラットフォームおよびその方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016177434A Expired - Fee Related JP6378273B2 (ja) | 2011-10-04 | 2016-09-12 | Ｅｃｍ組成物、腫瘍微小環境プラットフォームおよびその方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (7) | US20140228246A1 (enExample) |
| EP (1) | EP2764099B1 (enExample) |
| JP (2) | JP6147259B2 (enExample) |
| AU (1) | AU2012320088C1 (enExample) |
| CA (1) | CA2850274A1 (enExample) |
| CY (1) | CY1120087T1 (enExample) |
| DK (1) | DK2764099T3 (enExample) |
| ES (1) | ES2660975T3 (enExample) |
| HU (1) | HUE036537T2 (enExample) |
| NO (1) | NO2764099T3 (enExample) |
| PT (1) | PT2764099T (enExample) |
| SG (1) | SG11201401183UA (enExample) |
| TR (1) | TR201802420T4 (enExample) |
| WO (1) | WO2013050962A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105593438B (zh) | 2013-05-31 | 2019-07-05 | 伊顿智能动力有限公司 | 用于通过平衡保护来降低动臂跳动的液压系统及方法 |
| AU2014354599A1 (en) * | 2013-11-27 | 2016-06-09 | Research Foundation Of The City University Of New York | Activity enhancing curcumin compositions and methods of use |
| CN103966168B (zh) * | 2014-05-19 | 2017-05-03 | 广州恒迪生物科技有限公司 | 肿瘤活组织体外培养系统及培养方法 |
| WO2016154082A2 (en) * | 2015-03-23 | 2016-09-29 | Tang Yao | Methods of primary tissue culture and drug screening using autologous serum and fluids |
| GB2555252A (en) * | 2015-04-22 | 2018-04-25 | Ono Pharmaceutical Co | Method for extracting lead compound, method for selecting drug discovery target, device for generating scatter diagram, and data visualization method |
| GB201507894D0 (en) * | 2015-05-08 | 2015-06-24 | Imagen Biotech Ltd | Personalised media |
| KR102757122B1 (ko) * | 2015-10-20 | 2025-01-21 | 셀퀴티 인크. | 1차 세포 샘플을 제조하는 방법 |
| CN106047788A (zh) * | 2016-08-22 | 2016-10-26 | 上海逍鹏生物科技有限公司 | 一种适用于高密度细胞培养体系的培养基 |
| GB2555787A (en) | 2016-11-07 | 2018-05-16 | Landberg Goran | Diagnostic methods |
| WO2018148336A1 (en) * | 2017-02-08 | 2018-08-16 | Mitra Rxdx, Inc. | Method of predicting clinical outcome of anticancer agents |
| WO2018185760A1 (en) | 2017-04-05 | 2018-10-11 | Yeda Research And Development Co. Ltd. | Ex-vivo culture system and methods of using same |
| IL257225A (en) | 2018-01-29 | 2018-04-09 | Yeda Res & Dev | Treatment of sarcoma |
| WO2019164951A1 (en) * | 2018-02-22 | 2019-08-29 | Mitra Rxdx, Inc. | Methods of predicting response to temporally sequenced combination therapy |
| GB201818885D0 (en) | 2018-11-20 | 2019-01-02 | Precomb Therapeutics Ag | 3d human cancer model-based combinatiorial drug development method |
| WO2020172591A1 (en) * | 2019-02-22 | 2020-08-27 | Mitra Rxdx, Inc. | A method to predict a patient's response to an anti-cancer drug from an expression level of a set of genes |
| CA3130930A1 (en) * | 2019-03-19 | 2020-09-24 | Kyuson Yun | Methods and systems for evaluation of cell samples |
| CN112961830A (zh) * | 2021-02-25 | 2021-06-15 | 重庆医科大学附属口腔医院 | 口腔鳞癌组织脱细胞基质及其制备方法和应用 |
| CA3219233A1 (en) | 2021-06-06 | 2022-12-15 | Ravid STRAUSSMAN | Combined treatment for cancer |
| CN113774025B (zh) * | 2021-08-26 | 2023-07-14 | 湖南丰晖生物科技有限公司 | 一种结直肠癌顺铂耐药株的构建方法 |
| WO2023067582A1 (en) * | 2021-10-23 | 2023-04-27 | Mazumdar Shaw Medical Foundation | Tumor microenvironment platform comprising oral carcinoma for predicting drug sensitivity, drug resistance and disease progression |
| WO2023244699A1 (en) | 2022-06-15 | 2023-12-21 | SageMedic Corporation | A high-throughput multiplexed viability and proliferation assay |
| PL444462A1 (pl) * | 2023-04-18 | 2024-10-21 | Uniwersytet Medyczny W Białymstoku | Sposób oceny chemiowrażliwości komórek nowotworowych in vitro na leki przeciwnowotworowe i sposób diagnostyki ex vivo nowotworu piersi |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508188A (en) * | 1994-01-21 | 1996-04-16 | The Regents Of The University Of California | Method of growing cells in a mammal |
| FR2842822B1 (fr) * | 2002-07-26 | 2004-10-01 | Roussy Inst Gustave | Procede de preparation d'une matrice extracellulaire et son utilisation pour la culture de cellules tumorales |
| WO2008060377A2 (en) * | 2006-10-04 | 2008-05-22 | Anthrogenesis Corporation | Placental or umbilical cord tissue compositions |
| US20120213706A1 (en) * | 2009-04-15 | 2012-08-23 | University Of Medicine And Dentistry Of New Jersey | Reconstituted tumor microenvironment for anticancer drug development |
| WO2011148669A1 (ja) * | 2010-05-25 | 2011-12-01 | 株式会社 島津製作所 | 大腸がんマーカービトロネクチン、及び採血試料中のビトロネクチン濃度の分析方法 |
-
2012
- 2012-10-04 SG SG11201401183UA patent/SG11201401183UA/en unknown
- 2012-10-04 HU HUE12838648A patent/HUE036537T2/hu unknown
- 2012-10-04 ES ES12838648.9T patent/ES2660975T3/es active Active
- 2012-10-04 NO NO12838648A patent/NO2764099T3/no unknown
- 2012-10-04 CA CA2850274A patent/CA2850274A1/en not_active Abandoned
- 2012-10-04 EP EP12838648.9A patent/EP2764099B1/en not_active Not-in-force
- 2012-10-04 WO PCT/IB2012/055334 patent/WO2013050962A1/en not_active Ceased
- 2012-10-04 US US14/347,616 patent/US20140228246A1/en not_active Abandoned
- 2012-10-04 TR TR2018/02420T patent/TR201802420T4/tr unknown
- 2012-10-04 DK DK12838648.9T patent/DK2764099T3/en active
- 2012-10-04 AU AU2012320088A patent/AU2012320088C1/en not_active Ceased
- 2012-10-04 JP JP2014534027A patent/JP6147259B2/ja not_active Expired - Fee Related
- 2012-10-04 PT PT128386489T patent/PT2764099T/pt unknown
-
2016
- 2016-09-12 JP JP2016177434A patent/JP6378273B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-21 CY CY20181100194T patent/CY1120087T1/el unknown
- 2018-10-26 US US16/172,606 patent/US20190170730A1/en not_active Abandoned
-
2019
- 2019-05-24 US US16/422,023 patent/US20190383795A1/en not_active Abandoned
- 2019-05-24 US US16/422,045 patent/US20200064333A1/en not_active Abandoned
- 2019-05-24 US US16/422,031 patent/US20190353640A1/en not_active Abandoned
- 2019-05-24 US US16/422,052 patent/US20190383796A1/en not_active Abandoned
- 2019-05-24 US US16/422,059 patent/US20190346428A1/en not_active Abandoned